• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Biopharmaceutical study of aminophenazone-containing suppositories. 1. Experimental materials and methods, determination of physical qualities of the suppositories].

作者信息

Tantó M, Ecsy Z, Selmeczi B, Regdon G

机构信息

Borsod-Abaúj-Zemplén Megyei Tanács Gyógyszertári Központja, Miskolc.

出版信息

Acta Pharm Hung. 1990 Jul;60(4):143-8.

PMID:2239341
Abstract

Suppositories containing aminophenazone in quantities of 0.30 g/2 g were prepared by pouring technology. Two kinds of lipophilic suppository masses Witepsol W 35 and Estarinum 299 have been used as vehicles. Both of suppository bases are official in Ph. Hg. VII. As ingredients ten sorts of liquid tensides in concentrations of 5% have been applied. Experimental methods have been described: compression stability, disintegration time, special penetration time and drug release of suppositories by membrane diffusion method. Results of determinations have been discussed in the second part of the publication. On the basis of experimental results it has been established that the physical parameters of Massa Estarinum 299 had proved to be more advantageous. In 5% concentrations tensides softened consistency of suppositories favorably and shortened disintegration time beneficially in the case of both vehicles. The authors think that special penetration time is more suitable for measuring "disintegration" of suppositories of high powder content at 37 degrees C than the classical disintegration time.

摘要

相似文献

1
[Biopharmaceutical study of aminophenazone-containing suppositories. 1. Experimental materials and methods, determination of physical qualities of the suppositories].
Acta Pharm Hung. 1990 Jul;60(4):143-8.
2
[Biopharmaceutical study of aminophenazone-containing suppositories. 2. Results of in vitro drug release and in vivo drug absorption].
Acta Pharm Hung. 1990 Jul;60(4):149-55.
3
[Comparison of in vitro model examinaitons with respect to drug release from suppositories].
Acta Pharm Hung. 2000 Apr;70(2):45-51.
4
[Production technology and in vitro study of rectal suppositories containing chloroquine phosphate].
Acta Pharm Hung. 1995 Mar;65(2):45-50.
5
In vitro release of meclozine hydrochloride from lipophilic suppository bases with or without tensides.
Pharmazie. 1984 Dec;39(12):828-30.
6
[Acetaminophen-containing suppositories in vitro and in vivo].
Acta Pharm Hung. 1994 Mar;64(2):45-9.
7
[Formulation and analysis of suppositories containing papaverine hydrochloride. Part 2. In vitro membrane diffusion studies].
Acta Pharm Hung. 1991 Nov;61(6):303-9.
8
Studies on aminophenazone and phenobarbital release from suppositories prepared on different bases.不同基质制备的栓剂中氨基比林和苯巴比妥释放情况的研究。
Pol J Pharmacol Pharm. 1976;28(2):199-203.
9
[Preparation and in vitro study of suppositories containing No-Spa. II. Determination of release of the active principle by membrane diffusion methods].
Acta Pharm Hung. 1989 Jan;59(1):32-41.
10
Release of pyrazolone derivatives from suppositories formulated with hydrophilic and hydrophobic bases.
Pharmazie. 1986 May;41(5):338-40.